A Phase III Study of Deuremidevir Hydrobromide for the Treatment of RSV Infection in Infants and Young Children
Clinical trial NCT07402512 · RECRUITING
Trial details
- NCT number
- NCT07402512
- Sponsor
- Simcere Pharmaceutical Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-11
- Primary completion
- 2027-03-31
- Enrollment
- 498
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.